EGFR and colorectal carcinoma: CRC tumorigenesis is driven by molecular alterations resulting in activation of pro-survival signaling pathways such as the canonical WNT signaling pathway, the EGFR pathway, the TP53 network, and the transforming growth factor beta (TGF-β) (Figure 4).